Latest filing published 08 Mar 2016 for Targeted Medical Pharma, Inc., €9,133.
No signal scores available.
Thomas Richard Wenkart appears in our data through filings on Targeted Medical Pharma, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 30 June 2015 to 4 March 2016, the count stands at 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 8 March 2016: a share grant of €9,133, in Targeted Medical Pharma, Inc. The median gap between a trade and its publication by SEC (Form 4) is 35 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations